Cardinal Health Gestione

Gestione criteri di controllo 2/4

Cardinal Health Il CEO è Jason Hollar, nominato in Sep2022, e ha un mandato di 2.17 anni. la retribuzione annua totale è $ 25.65M, composta da 5.6% di stipendio e 94.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.008% delle azioni della società, per un valore di € 2.04M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.2 anni e 4.3 anni.

Informazioni chiave

Jason Hollar

Amministratore delegato

US$25.7m

Compenso totale

Percentuale dello stipendio del CEO	5.6%
Mandato del CEO	2.2yrs
Proprietà del CEO	0.008%
Durata media del management	2.2yrs
Durata media del Consiglio di amministrazione	4.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Jason Hollar rispetto agli utili di Cardinal Health?
Data	Compenso totale	Stipendio	Guadagni aziendali
Sep 30 2024	n/a	n/a	US$1b
Jun 30 2024	US$26m	US$1m	US$852m
Mar 31 2024	n/a	n/a	US$604m
Dec 31 2023	n/a	n/a	US$691m
Sep 30 2023	n/a	n/a	US$208m
Jun 30 2023	US$19m	US$1m	US$330m
Mar 31 2023	n/a	n/a	US$463m
Dec 31 2022	n/a	n/a	-US$1b
Sep 30 2022	n/a	n/a	-US$1b
Jun 30 2022	US$4m	US$729k	-US$938m
Mar 31 2022	n/a	n/a	-US$955m
Dec 31 2021	n/a	n/a	US$555m
Sep 30 2021	n/a	n/a	US$1b
Jun 30 2021	US$4m	US$700k	US$611m
Mar 31 2021	n/a	n/a	US$1b
Dec 31 2020	n/a	n/a	US$1b
Sep 30 2020	n/a	n/a	US$973m
Jun 30 2020	US$4m	US$124k	-US$4b

Compensazione vs Mercato: La retribuzione totale di Jason ($USD 25.65M ) è superiore alla media delle aziende di dimensioni simili nel mercato German ($USD 4.87M ).

Compensazione vs guadagni: La retribuzione di Jason è aumentata di oltre il 20% nell'ultimo anno.

AMMINISTRATORE DELEGATO

Jason Hollar (51 yo)

2.2yrs

Mandato

US$25,650,709

Compensazione

Mr. Jason M. Hollar has been Chief Executive Officer of Cardinal Health, Inc. since September 01, 2022. He serves as Director at Cardinal Health, Inc. from August 11, 2022 and had been Chief Financial Offi...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Jason Hollar	CEO & Director	2.2yrs	US$25.65m	0.0075% € 2.0m
Aaron Alt	Chief Financial Officer	1.8yrs	US$6.84m	0.0013% € 340.8k
Jessica Mayer	Chief Legal & Compliance Officer	5.7yrs	US$4.66m	0.011% € 2.9m
Stephen Mason	Chief Executive Officer of Medical Segment	5.3yrs	US$7.34m	0% € 0
Deborah Weitzman	Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment	2.2yrs	US$5.09m	0.0083% € 2.3m
Mary Scherer	Senior VP & Chief Accounting Officer	2.2yrs	Nessun dato	0.0036% € 979.1k
Michelle Greene	Executive VP	2.3yrs	Nessun dato	0.0080% € 2.2m
Matt Sims	Vice President of Investor Relations	no data	Nessun dato	Nessun dato
Ola Snow	Chief Human Resources Officer	6.1yrs	Nessun dato	0.011% € 3.1m
Craig Cowman	Executive Vice President of Biopharma Solutions & Strategic Sourcing	no data	Nessun dato	Nessun dato
Patricia English	Senior Vice President	1.8yrs	US$1.26m	0.0020% € 551.8k
Ben Brinker	President of Global Products & Supply Chain	3.7yrs	Nessun dato	Nessun dato

2.2yrs

Durata media

53yo

Età media

Gestione esperta: Il team dirigenziale di CLH è considerato esperto (durata media dell'incarico 2.2 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Jason Hollar	CEO & Director	2.3yrs	US$25.65m	0.0075% € 2.0m
Gregory Kenny	Independent Non-Executive Chairman	17.3yrs	US$570.10k	0% € 0
Christine Ann Mundkur	Independent Director	2.2yrs	US$318.09k	0% € 0
Patricia Hemingway Hall	Independent Director	11.2yrs	US$338.09k	0.0045% € 1.2m
David Evans	Independent Director	4.3yrs	US$320.09k	0% € 0
Sheri Edison	Independent Director	4.2yrs	US$338.09k	0.0017% € 454.4k
Nancy Killefer	Independent Director	9.2yrs	US$330.61k	0% € 0
Akhil Johri	Independent Director	6.8yrs	US$345.09k	0% € 0
Robert Azelby	Independent Director	less than a year	US$182.66k	0% € 0
Michelle Brennan	Independent Director	2.2yrs	US$318.09k	0.0022% € 592.3k

4.3yrs

Durata media

62yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di CLH sono considerati esperti (durata media dell'incarico 4.3 anni).

Cardinal Health Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Cardinal Health, Inc., Annual General Meeting, Nov 06, 2024

Cardinal Health, Inc. Announces Board Changes

CEO & Director recently sold €7.2m worth of stock

Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024

Cardinal Health, Inc., Annual General Meeting, Nov 15, 2023

Chief Legal & Compliance Officer recently sold €3.2m worth of stock

Recent updates

Cardinal Health, Inc. (NYSE:CAH) entered into definitive agreement to acquire Advanced Diabetes Supply Group from Court Square Capital Management, L.P. for approximately $1.1 billion.

First quarter dividend of US$0.51 announced

First quarter 2025 earnings released: EPS: US$1.71 (vs US$0.02 in 1Q 2024)

Cardinal Health, Inc. to Report Q1, 2025 Results on Nov 01, 2024

Upcoming dividend of US$0.51 per share

Cardinal Health, Inc., Annual General Meeting, Nov 06, 2024

Cardinal Health, Inc. Announces Board Changes

CEO & Director recently sold €7.2m worth of stock

Fourth quarter dividend of US$0.51 announced

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2024

Full year 2024 earnings released: EPS: US$3.48 (vs US$1.00 in FY 2023)

Cardinal Health, Inc. Provides Earnings Guidance for the Fiscal Year 2025

Cardinal Health, Inc. to Report Q4, 2024 Results on Aug 14, 2024

Third quarter dividend of US$0.51 announced

Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024

Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024

Third quarter 2024 earnings released: EPS: US$1.06 (vs US$1.35 in 3Q 2023)

Cardinal Health, Inc. to Report Q3, 2024 Results on May 02, 2024

Upcoming dividend of US$0.50 per share

Cardinal Health, Inc. Elects Robert "Bob" Azelby as Independent Director, Effective March 1, 2024

Second quarter dividend of US$0.50 announced

Cardinal Health Approves Quarterly Dividend, Payable on April 15, 2024

Second quarter 2024 earnings released: EPS: US$1.44 (vs US$0.50 loss in 2Q 2023)

Cardinal Health, Inc. (NYSE:CAH) entered into a definitive agreement to acquire Specialty Networks, LLC for $1.2 billion.

Cardinal Health, Inc. Provides Earnings Guidance for the Year 2024

Upcoming dividend of US$0.50 per share at 2.0% yield

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on January 15, 2024

Cardinal Health Launches Smartgown™ Edge Breathable Surgical Gown with Assist™ Instrument Pockets

First quarter 2024 earnings released: EPS: US$0.02 (vs US$0.41 in 1Q 2023)

Cardinal Health Launches Kangaroo OMNI Enteral Feeding Pump

Cardinal Health, Inc., Annual General Meeting, Nov 15, 2023

Cardinal Health, Inc. to Report Q1, 2024 Results on Nov 03, 2023

Upcoming dividend of US$0.50 per share at 2.3% yield

Chief Legal & Compliance Officer recently sold €3.2m worth of stock

Cardinal Health, Inc. Reiterates Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings released: EPS: US$1.00 (vs US$3.34 loss in FY 2022)

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2023

Transaction Data Systems, Inc. completed the acquisition of Outcomes Inc from Cardinal Health.

Transaction Data Systems, Inc. completed the acquisition of Outcomes Inc from Cardinal Health.

Cardinal Health, Inc. to Report Q4, 2023 Results on Aug 15, 2023

Upcoming dividend of US$0.50 per share at 2.2% yield

Cardinal Health, Inc. (NYSE:CAH) announces an Equity Buyback for $3,500 million worth of its shares.

Transaction Data Systems, Inc. agreed to acquire Outcomes business of Cardinal Health.

Cardinal Health Launches Modern Commerce Solutions for Retail Independent Pharmacies Powered by Square

Now 20% undervalued

Cardinal Health, Inc. Announces Quarterly Dividend, Payable on July 15, 2023

Third quarter 2023 earnings released: EPS: US$1.35 (vs US$5.06 loss in 3Q 2022)

Upcoming dividend of US$0.50 per share at 2.9% yield

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on April 15, 2023

Cardinal Health, Inc. Revises Earnings Guidance for the Fiscal Year 2023

Second quarter 2023 earnings released: US$0.50 loss per share (vs US$0.18 profit in 2Q 2022)

Cardinal Health, Inc. to Report Q2, 2023 Results on Feb 02, 2023

Upcoming dividend of US$0.50 per share

Cardinal Health, Inc Announces Executive Changes, Effective February 10, 2023

Insider recently sold €3.6m worth of stock

Cardinal Health Announces the Launch of Velocare

Insider recently sold €3.6m worth of stock

Cardinal Health, Inc. Approves Quarterly Dividend, Payable on January 15, 2023

First quarter 2023 earnings released

Cardinal Health, Inc., Annual General Meeting, Nov 09, 2022

Cardinal Health, Inc. to Report Q1, 2023 Results on Nov 04, 2022

Upcoming dividend of US$0.50 per share

Cardinal Health Announces Executive Changes

Cardinal Health, Inc. Announces Executive Appointments

High number of new directors

Full year 2022 earnings released: US$3.34 loss per share (vs US$2.09 profit in FY 2021)

Cardinal Health Approves Quarterly Dividend, Payable on October 15, 2022

Cardinal Health Appoints Michelle Greene as Chief Information Officer

Cardinal Health, Inc. (NYSE:CAH) acquired Bendcare CPO-GPO entity from Bendcare.